The prevalence of depression is high in cancer patients. In the process of initiation, maintenance and completion of treatment, the detection of depression is closely associated with treatment outcomes. Therefore, awareness of this issue is of great significance at present. In view of the aforementioned information, the aim of the present study is to investigate the severity of depressive symptoms and factors that can lead to depression in cancer patients receiving outpatient chemotherapy. Patients receiving chemotherapy in Diskapi Training and Research hospital and volunteering to participate in the study, were administered Beck Depression Inventory and asked to fill sociodemographic data form. The present study was carried out with 100 patients (55 female, 45 male) receiving treatment in outpatient chemotherapy unit. High depression score was detected in 21 (%) patients. In the evaluation of the factors influencing high depression score, the rate of high depression score was found to be higher in female patients (p: 0.03). Similarly the rate of high depression score was higher in patients at metastatic stage (p: 0.01). Apart from these, no other factor was found to be associated with high depression score. Depression is one of the factors that affect treatment compliance and prognosis of the disease. Therefore, awareness of this issue is quite important. Cancer treatment requires a multidisciplinary approach and in this patient groups, those with depressive characteristics should be especially supported.
___
1.Lepore SJ, Coyne JC. Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med 2006; 32: 85-92.
2. Berard RM, Depression and anxiety in oncology: the psychiatrist's perspective. J Clin Psychiatry 200; 8: 58-61.
3. Arslan S, Çelebioğlu A, and Tezel A. Kemoterapi alan kanserli hastalarda depresyon ve yaşam doyumunun belirlenmesi. Türkiye Klinikleri J med Sci 2008; 28: 628-634.
4. Breitbart W, Rosenfelt B, Pessin H et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. Jama 2000; 284: 2907-2911.
5. Mitchell AJ, Chan M, Bhatti H et al. Prevalence of depression, anxiety and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-174.
6. Sertöz ÖÖ, Mete HE. Bedensel hastalıklarda depresyon. Klinik Psikiyatri 2004: 63-69.
7. Jemal A, Siegel R, Xu J et al. Cancer statistics 2010. CA Cancer J Clin 2010; 60: 277-300.
8. Tokgöz G, Yaluğ İ, Özdemir S, Yazıcı A, Uygun K, Aker T. Kanser hastalarında majör depresyon yaygınlığı ve ilişkili etkenler. Anadolu Psikiyatri Dergisi 2008: 59-66.
9. Sloan PA, LaFountain P, Plymale M, Johnson M, Snapp J, Sloan DA. Cancer pain education for medical students: the development of a short course on CD-ROM. Pain Med 2002; 3(1): 66-72.
10. Grassi L, Berardi MA, Ruffilli F et al. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom 2015; 84(6): 339-347.
11. Caruso R, GiuliaNanni M, Riba MB, Sabato S, Grassi L. Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review. Curr Psychiatry Rep 2017; 19: 33.
12. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115: 5349-5361.
13. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-858.
14. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
15. Hisli N. Beck depresyon envanterinin üniversite öğrencileri için geçerliği ve güvenirliği. Türk Psikoloji Dergisi 1989; 7(23): 3-13.
16. Bostanci M, Ozdel O, Kalkan N et al. Depressive symptomatology among university students in Denizli, Turkey: prevalence and sociodemographic correlates. Croat Med J 2005; 46: 96-100.
17. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 2012; 141: 343-351.
18. Aydogan U, Doğaner YÇ, Borazan E, et al. Relationship between depression and anxiety levels and attitudes of coping with disease in cancer patients. Türk Aile Hek Derg 2012; 16: 55-60.
19. Von Essen L, Enskar K, Kreuger A, Larsson B, Sjöden PO. Self-esteem, depression and anxiety among Swedish children and adolescents on and off cancer treatment. Acta Paediatr 2000; 89: 229-236.
20. Shaik S, Rajkumar RP, Menon V, Sarkar S. Gender, Life Events, and Depression: An Exploratory Study. Indian J Psychol Med 2017; 39: 330-335.
21. Pandey M, Sarita GP, Devi N, Thomas BC, Hussain BM, Krishnan R. Distress, anxiety, and depression in cancer patients undergoing chemotherapy. World J Surg Oncol 2006; 4: 68.
22. Kaplan GA, Roberts RE, Camacho TC, Coyne JC. Psychosocial predictors of depression. Prospective evidence from the human population laboratory studies. Am J Epidemiol 1987; 125: 206-220.
23. McCall NT, Parks P, Smith K, Pope G, Griggs M. The prevalence of major depression or dysthymia among aged Medicare Fee-for-Service beneficiaries. Int J Geriatr Psychiatry 2002; 17: 557-565.
24. Jacob L, Kalder M, Kostev K. Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany. Psychooncology 2017; 26: 1535-1540.
25. Lin PH, Liu JM, Hsu RJ et al. Depression Negatively Impacts Survival of Patients with Metastatic Prostate Cancer. Int J Environ Res Public Health 2018; 15 (10).